88 Episoder

  1. Acute hepatitis C

    Publisert: 8.3.2019
  2. Epidemiology of chronic liver disease

    Publisert: 8.2.2019
  3. Viral hepatitis in migrant populations

    Publisert: 7.12.2018
  4. DAA treatment for hepatitis C among people who inject drugs

    Publisert: 25.10.2018
  5. Pancreatic cancer treatment

    Publisert: 6.9.2018
  6. UDCA Response Score

    Publisert: 10.8.2018
  7. Global prevalence, treatment, and prevention of hepatitis B virus infection

    Publisert: 3.5.2018
  8. Neoplasia detection in ulcerative colitis

    Publisert: 6.4.2018
  9. Functional dyspepsia

    Publisert: 8.3.2018
  10. Can DAA therapy for HCV reactivate HBV in coinfected patients?

    Publisert: 8.2.2018
  11. Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018

    Publisert: 13.1.2018
  12. Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018

    Publisert: 9.12.2017
  13. PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017

    Publisert: 9.11.2017
  14. Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017

    Publisert: 2.9.2017
  15. Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017

    Publisert: 19.8.2017
  16. Oesophageal motility and solid meal tests: The Lancet Gastroenterology & Hepatology: August 2, 2017

    Publisert: 3.8.2017
  17. HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017

    Publisert: 6.7.2017
  18. Early intervention for alcohol-related liver disease: The Lancet Gastroenterology and Hepatology: June 7, 2017

    Publisert: 8.6.2017
  19. Stem cell transplantation in Crohn's: The Lancet Gastroenterology & Hepatology: May 5, 2017

    Publisert: 5.5.2017
  20. Colorectal cancer in sub-Saharan Africa: The Lancet Gastroenterology & Hepatology: April 5, 2017

    Publisert: 6.4.2017

4 / 5

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Visit the podcast's native language site